Early career: Mr. Ohashi was Director of Strategic Business Development at SRL. Responsible for the development of new business activities and item introduction. Taken on a management role for introducing clinical examination system and bio-sensor technology at various companies including Beckman and Pharmacia. At 1999, Mr. Ohashi had been disignated as Managed representative roles at Proteome Systems in Australia to negotiate the introduction of proteomic studies. In 2002, Mr. Ohashi established Proteome Systems Japan (a joint enterprise with Ito Atsushi Company). CEO. Successfully managed the development and set up of Kurume Translational Research Centre. 2004 ? present: Have been managing the translation of life science to clinical application and development. Currently working as a business consultant and advisor for bio- and life-science related manufacturers in Japan, US and Australia. |
2008 | Established Bio Renaissance Pty Ltd. Role: CEO.; strategic consulting for Life Science and Medical industries. |
Established Japan corporation of MTM Laboratories (Germany) to successfully reach the Japanese market. Role: CEO and Directing Manager. | |
2004 | Established Cytyc Corporation (US) Japan branch. Role: Directing Manager. |
2002 | Established Proteome Systems Japan (a joint enterprise) with C-Ito Corporation. |
1998 | Proteome Systems Laboratories (Australia); Role: Japanese Country Manager |
1991 | Bio-Sensor Manager (Pharmacia; GE Healthcare) Senior executive manager (Deltec) |
1987 | Diagnostic Medicine Marketing Director (Beckman; now Beckman Coulter) |
1977 | Operations and Development Manager (Special Reference Laboratory; now SRL) |
Strategic business planning and advice | Overseas firm (US, Australia, Germany, France, North Europe) and Japanese firms. |
Planning for successful launch in to the Japanese market. | Supporting to establish the business utilities in Japan for foreign base companies, e.x. US, Australia, France |
Market research and analysis | US, Germany, and Japanese companies. |
International strategic planning for Japanese companies | Partnering, market research and registration. |
Technology and project development and support | Diagnostic medicine. Medical equipments. Drugs development. Clinical studies. |